基本信息
浏览量:8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
As a scientist, he is known for first identifying and cloning the leptin receptor in 1995, a discovery that prompted immediate coverage in US national media given its expected clinical significance. He is also known for studying signaling mechanisms from the tumor necrosis factor (TNF) receptors, and for publishing studies in the fields of obesity and diabetes which are often discussed in subject reviews. After moving from academia to industry in 1990, for over a decade he accompanied the growth of Millennium Pharmaceuticals, reaching top positions within the company. From executive roles he has occupied in venture capital firms, and as a member of several advisory boards, Tartaglia has helped start a number of therapeutics oriented companies that have found their way into the market, among them Agios,[8] Editas,[9] Rhythm,[10] and Zafgen.
研究兴趣
论文共 80 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alexandra Glucksmann,Deborah Palestrant,Louis Anthony Tartaglia, Jordi Matafink, Agnieszka Dorota Czechowicz, Alexis Borisy
mag(2015)
引用27浏览0引用
27
0
mag(2013)
引用23浏览0引用
23
0
Louis A Tartaglia, Thomas Michael Barnes,Robert Mark Coopersmith, Scott Edward Malstrom, David W White,Luzmaria Guzman
mag(2009)
引用25浏览0引用
25
0
Louis A Tartaglia, Thomas Michael Barnes,Robert Mark Coopersmith, Scott Edward Malstrom, David W White,Dominic Picarella
mag(2008)
引用33浏览0引用
33
0
Louis A Tartaglia, Thomas Michael Barnes,Robert Mark Coopersmith, Scott Edward Malstrom, David W White,Dominic Picarella
mag(2008)
引用27浏览0引用
27
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn